Safety and Effectiveness Study of Intranasal Insulin Glulisine on Cognitive and Memory in Mild-Mod AD Patients.
Status:
Completed
Trial end date:
2013-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to investigate the effect of the rapidly acting intranasal
insulin derivative (glulisine) on memory and cognition in 12 patients suffering from
mild-moderate Alzheimer's Disease (AD) using a double-blind placebo-controlled single dose
study. This study will further assess safety of insulin glulisine as well as the effects of
this drug on olfaction.